PLANNING AND EVALUATION (Core 001)
PLANNING AND EVALUATION (Core 001)
批准号:
8998397
负责人:
CHI V. DANG
金额:
$5.27万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-15 至 2020-11-30
关键词:
Advisory CommitteesAppointmentAreaBasic ScienceBehavior TherapyCancer CenterCancer Center Support GrantCancer ControlChargeClinicalClinical ResearchClinical TrialsCollaborationsComplementDecision MakingDevelopmentDisciplineEnsureEquilibriumEvaluationFeedbackFosteringFundingFutureGoalsGrantGrowth and Development functionGuidelinesInstitutionInvestmentsLaboratoriesMolecular ProfilingMonitorNCI Center for Cancer ResearchPopulation SciencesProcessProgram ReviewsRecommendationReportingResearchResearch PersonnelResource AllocationResource SharingResourcesSeriesStrategic PlanningSurveysTimeTranslational ResearchTranslationsVisionanticancer researchcancer riskexperienceinnovationmeetingsmemberoperationpersonalized medicineprecision medicineprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The Abramson Cancer Center (ACC) has a well-established internal, Institutional, and external Planning and
Evaluation (P&E) process that engages leaders, members, and advisors from multiple disciplines, perspectives
and levels. The goal of this process is to guide future directions, set priorities and prioritize investments of the
Center while, at the same time, providing ongoing mechanisms to monitor, assess and adjust research
progress, Programs, Shared Resources, allocations, and strategies. This cohesive process is supported by
highly integrated and effective bodies, such as the Senior Leaders, Executive Committee, Program Leaders,
Shared Resource Advisory Committees, and the External Scientific Advisory Board (ESAB), which provides
critical advice and feedback from experts. The Planning and Evaluation process has resulted in changes in
Program focus, development of new Cores, changes in clinical research operations, and prioritization of
Developmental Funds. Complementing these efforts are Programmatic, Divisional and Center-wide research
seminars, meetings and retreats that foster new interactions and collaborations with Penn colleagues and
external experts. Strategic planning is embedded in the ACC and Penn culture. The ACC plan of 2008-2013
set forth the goals for this period, including accelerating the translation of basic science discoveries into
investigator-initiated clinical trials, establishing a comprehensive molecular profiling and personalized medicine
initiative, enhancing behavioral interventions to reduce cancer risk, and promoting translation of ACC research.
Soon after his appointment, the Center Director, Dr. Dang, defined his vision through 2020, and charged a
group to recommend strategies to realize the Center's goals in translational research and precision medicine.
A defining accomplishment has been $20M from the Institution to establish innovative transdisciplinary
programmatic efforts in translational cancer research, which are fueled by multi-year Institutional grants and
resources in high priority areas. Rigorous internal review of Programs, Shared Resources, Developmental
Funds, and strategic plan reviews by the ESAB ensure that the ACC continues to strive for excellence and
adheres to NCI guidelines. The ACC responds to all ESAB recommendations and then reports on its actions.
Taken together, the integrated P&E processes have successfully guided the growth and development of the
ACC during the project period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10205608
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10728412
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10623158
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10396617
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6474169
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6528030
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6651086
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
FASEB conference on Hematological Malignancies
-
批准号:6359970
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8710658
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9131243
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8402161
-
项目类别:
-
资助金额:$721.69万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8998395
-
项目类别:
-
资助金额:$797.55万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
DEVELOPMENTAL FUNDS (Core 002)
-
批准号:8998398
-
项目类别:
-
资助金额:$99.53万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9338556
-
项目类别:
-
资助金额:$50.0万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8789009
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8300800
-
项目类别:
-
资助金额:$772.51万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9378876
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:6375935
-
项目类别:
-
资助金额:$40.95万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:6641317
-
项目类别:
-
资助金额:$43.45万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
C-MYC Targets in the Pathogenesis of Human Cancer
-
批准号:7071170
-
项目类别:
-
资助金额:$39.8万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
海外基金